A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC-Reference-Cited by-同舟云学术

A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC

Published:2008-08 Issue:36 Volume:26 Page:4731-4739
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

McKenzie Robin,Darsley Michael,Thomas Nicola,Randall Roger,Carpenter Colleen,Forbes Edrick,Finucane Mariel,Sack R. Bradley,Hall Eric,Bourgeois August L.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference20 articles.

1. New frontiers in the development of vaccines against enterotoxinogenic (ETEC) and enterohaemorrhagic (EHEC) E. coli infections. Part I. Wkly Epidemiol Rec 1999 2;74(13):98–101.

2. Immunity to enterotoxigenic Escherichia coli;Levine;Infect Immun,1979

3. Epidemiology of diarrhoeal disease: implications for control by vaccines;Black;Vaccine,1993

4. Comparative susceptibility of Latin American and United States students to enteric pathogens;DuPont;N Engl J Med,1976

5. Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico;Adachi;J Infect Dis,2002

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bismuth subsalicylate, probiotics, rifaximin and vaccines for the prevention of travelers’ diarrhea: a systematic review and network meta-analysis;Frontiers in Pharmacology;2024-04-18

2. A First in Human Clinical Trial Assessing the Safety and Immunogenicity of Two Intradermally Delivered Enterotoxigenic Escherichia coli CFA/I Fimbrial Tip Adhesin Antigens with and without Heat-Labile Enterotoxin with Mutation LT(R192G);Microorganisms;2023-11-02

3. Heat-Labile Enterotoxin Decreases Macrophage Phagocytosis of Enterotoxigenic Escherichia coli;Microorganisms;2023-08-21

4. Controlled Human Infection Models To Accelerate Vaccine Development;Clinical Microbiology Reviews;2022-09-21

5. Whole Genome Sequencing and CRISPR/Cas9 Gene Editing of Enterotoxigenic Escherichia coli BE311 for Fluorescence Labeling and Enterotoxin Analyses;International Journal of Molecular Sciences;2022-07-06